Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 1:26 pm Unchanged | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | The Vanguard Group | 9,226,884 7.840% | 0 (Unchanged) | Filing History |
| 2024-11-08 1:56 pm Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | Wellington Management Group LLP | 7,030,949 5.970% | 7,030,949 (New Position) | Filing History |
| 2024-11-04 10:22 am Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | The Vanguard Group | 9,226,884 7.840% | 5,183,705 (+128.21%) | Filing History |
| 2024-08-23 5:46 pm Purchase | 2024-08-22 | 13D | Avidity Biosciences, Inc. RNA | RTW Investments, LP | 12,079,734 9.990% | 2,419,925 (+25.05%) | Filing History |
| 2024-05-06 5:57 pm Purchase | 2024-04-26 | 13G | Avidity Biosciences, Inc. RNA | RA Capital Management, L.P. | 4,895,959 5.100% | 2,441,426 (+99.47%) | Filing History |
| 2024-03-11 1:12 pm Purchase | 2024-02-29 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 9,656,852 12.100% | 2,738,942 (+39.59%) | Filing History |
| 2024-03-01 4:15 pm Purchase | 2024-02-28 | 13D | Avidity Biosciences, Inc. RNA | RTW Investments, LP | 9,659,809 9.990% | 2,958,320 (+44.14%) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | Avidity Biosciences, Inc. RNA | RA Capital Management, L.P. | 2,454,533 3.300% | -3,000,000 (-55.00%) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 6,917,910 9.300% | 210,623 (+3.14%) | Filing History |
| 2024-02-13 4:59 pm Purchase | 2023-12-29 | 13G | Avidity Biosciences, Inc. RNA | The Vanguard Group | 4,043,179 5.460% | 572,553 (+16.50%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 10,404,096 14.040% | -218,767 (-2.06%) | Filing History |
| 2024-02-02 12:08 pm Purchase | 2023-12-29 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 5,629,103 7.600% | 440,737 (+8.49%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 6,496,593 8.800% | 1,210,419 (+22.90%) | Filing History |
| 2024-01-24 08:13 am Purchase | 2024-01-24 | 13D | Avidity Biosciences, Inc. RNA | RTW Investments, LP | 6,701,489 8.400% | 744,931 (+12.51%) | Filing History |
| 2024-01-23 09:38 am Sale | 2023-12-31 | 13G | Avidity Biosciences, Inc. RNA | STATE STREET CORP STT | 3,438,328 4.640% | -131,799 (-3.69%) | Filing History |
| 2023-12-04 4:13 pm Purchase | 2023-11-27 | 13G | Avidity Biosciences, Inc. RNA | BRISTOL MYERS SQUIBB CO BMY | 5,075,304 6.400% | 5,075,304 (New Position) | Filing History |
| 2023-07-10 10:20 am Purchase | 2023-07-07 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 10,622,863 14.999% | 5,697,486 (+115.68%) | Filing History |
| 2023-02-14 1:36 pm Sale | 2022-12-31 | 13G | Avidity Biosciences, Inc. RNA | EcoR1 Capital, LLC | 0 0.000% | -2,759,505 (Position Closed) | Filing History |
| 2023-02-14 12:38 pm Purchase | 2022-12-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 6,707,287 10.100% | 1,627,761 (+32.05%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Avidity Biosciences, Inc. RNA | The Vanguard Group | 3,470,626 5.220% | 3,470,626 (New Position) | Filing History |